indiana-university-school-medicine

Migration, Crosslink

📖

indiana-university-school-medicine

active

wiki page Created: 2026-04-02T07:20:11 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-institutions-indiana-university-sch

📖 Wiki Page

institution2501 wordssynced 2026-04-02

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">Indiana University School of Medicine</th>
</tr>
<tr>
<td class="label">Location</td>
<td>Indianapolis, Indiana, USA</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Medical School / Research University</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1903</td>
</tr>
<tr>
<td class="label">Enrollment</td>
<td>~1,700 medical students</td>
</tr>
<tr>
<td class="label">Faculty</td>
<td>~1,300 faculty members</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://medicine.iu.edu" target="_blank">https://medicine.iu.edu</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>Alzheimer's Disease, Parkinson's Disease, Neurodegeneration, Neuroimaging, Biomarkers</td>
</tr>
</table>

Indiana University School of Medicine

Introduction

The Indiana University School of Medicine (IUSM) is the largest medical school in Indiana and one of the nation's leading research institutions for neurodegenerative diseases. Located in Indianapolis, IUSM has established itself as a premier center for Alzheimer's disease, Parkinson's disease, and related neurological disorders research[@indiana]. The institution's commitment to translational neuroscience has resulted in significant advances in biomarker discovery, genetic research, and therapeutic development.

...

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">Indiana University School of Medicine</th>
</tr>
<tr>
<td class="label">Location</td>
<td>Indianapolis, Indiana, USA</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Medical School / Research University</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1903</td>
</tr>
<tr>
<td class="label">Enrollment</td>
<td>~1,700 medical students</td>
</tr>
<tr>
<td class="label">Faculty</td>
<td>~1,300 faculty members</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://medicine.iu.edu" target="_blank">https://medicine.iu.edu</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>Alzheimer's Disease, Parkinson's Disease, Neurodegeneration, Neuroimaging, Biomarkers</td>
</tr>
</table>

Indiana University School of Medicine

Introduction

The Indiana University School of Medicine (IUSM) is the largest medical school in Indiana and one of the nation's leading research institutions for neurodegenerative diseases. Located in Indianapolis, IUSM has established itself as a premier center for Alzheimer's disease, Parkinson's disease, and related neurological disorders research[@indiana]. The institution's commitment to translational neuroscience has resulted in significant advances in biomarker discovery, genetic research, and therapeutic development.

The school's research enterprise is anchored by the Stark Neurosciences Research Institute, established in 2007 as a centerpiece for neuroscience research that brings together basic scientists and clinicians to accelerate discoveries in brain health and disease. This integrated approach has positioned IUSM at the forefront of neurodegenerative disease research in the United States.

Historical Development

Foundation and Early Growth

Indiana University School of Medicine was founded in 1903, beginning as a two-year basic science program that expanded over decades to become a comprehensive four-year medical school. The early focus on medical education laid the foundation for the institution's later research prominence.

Throughout the 20th century, IUSM grew incrementally, adding new departments and research programs. The establishment of the Department of Neurology in the 1960s marked the beginning of the school's systematic approach to neurodegenerative disease research.

The Stark Neurosciences Research Institute

The Stark Neurosciences Research Institute was established in 2007 through a transformative gift from the Stark family, creating a unified home for neuroscience research at Indiana University. The institute brought together researchers from multiple departments and schools, fostering interdisciplinary collaboration that has become a hallmark of the institution's research culture[@indiana].

The institute's creation enabled:

Integrated research programs: Basic scientists and clinicians working side by side on shared problems
Shared resources: State-of-the-art core facilities for imaging, genomics, and behavioral assessment
Training opportunities: Comprehensive programs for the next generation of neuroscience researchers
Industry partnerships: Collaborations with pharmaceutical and biotechnology companies

The Indiana Alzheimer Disease Center

The Indiana Alzheimer Disease Center (IADC) was established in 1999 with funding from the National Institute on Aging, becoming one of the original network of Alzheimer's Disease Research Centers. Over the past 25 years, the IADC has contributed significantly to understanding the biomarkers, genetics, and clinical manifestations of Alzheimer's disease[@bateman2024].

Key milestones include:

1999: Center established with initial NIA funding
2005: Expanded clinical research program
2010: Integration with Stark Neurosciences Research Institute
2015: Launch of biomarker validation studies
2020: Enhanced computational neuroscience capabilities

Research Infrastructure

Campus and Facilities

IUSM is located on the Indiana University-Purdue University Indianapolis (IUPUI) campus, a vibrant academic health science center. The campus features modern research facilities designed for interdisciplinary collaboration[@risacher2023].

Stark Neurosciences Research Institute

The institute occupies over 150,000 square feet of research space, housing:

Molecular biology laboratories: Equipment for gene expression, protein analysis, and cell culture
Imaging facilities: MRI, PET, and small animal imaging systems
Behavioral neuroscience laboratories: Space for cognitive testing and behavioral assessment
Electrophysiology core: Equipment for EEG, EMG, and single-unit recording

Indiana University Health Neuroscience Center

The clinical facility provides:

Outpatient clinics: Memory disorders, movement disorders, and general neurology
Clinical trials unit: Dedicated space for therapeutic studies
Infusion center: Administration of experimental therapies
Day hospital: Complex diagnostic evaluations

Research Centers and Programs

IUSM houses several specialized research centers focused on neurodegenerative diseases:

Indiana Alzheimer Disease Center

The IADC is one of 33 NIH-funded Alzheimer's Disease Research Centers in the United States. The center's research program encompasses:

Biomarker research: CSF, blood, and imaging biomarkers for early detection
Genetics: Whole genome studies and targeted genetic analyses
Clinical characterization: Detailed cognitive and behavioral assessments
Neuropathology: Brain bank for post-mortem studies

Parkinson's Disease Research Center

The movement disorders program includes:

Deep brain stimulation: Surgical program with over 500 implanted patients
Clinical trials: Novel therapeutic agents and devices
Biomarker studies: Identification of progression markers
Non-motor symptoms: Research on cognitive and psychiatric manifestations

Center for Neurobiology of Learning and Memory

This basic science center investigates:

Synaptic plasticity: Mechanisms of memory formation and dysfunction
Neural circuits: Connectivity patterns in aging and disease
Computational models: Simulation of neural network dysfunction

Center for Vascular and Integrative Neuroscience

Research on cerebrovascular contributions to cognitive impairment:

Vascular dementia: Clinical and pathological characterization
Mixed pathology: Interaction of vascular and neurodegenerative processes
Preventive strategies: Risk factor modification

Core Facilities

The institution provides shared research resources:

| Facility | Services |
|----------|----------|
| MRI Core | Human and animal imaging, advanced sequences |
| PET Core | Radiotracer synthesis, small animal PET |
| Genomics Core | Whole genome sequencing, gene expression arrays |
| Proteomics Core | Mass spectrometry, protein identification |
| Behavioral Core | Cognitive testing, mouse phenotyping |
| Bioinformatics Core | Data analysis, computational resources |

Alzheimer's Disease Research Program

Overview

Mermaid diagram (expand to render)

The Alzheimer's disease research program at IUSM represents one of the nation's most comprehensive efforts to understand and treat this condition. The program integrates basic science research with clinical investigation, creating a pipeline from laboratory discovery to patient care["@bateman2024"].

Current Research Directions

Biomarker Studies

Researchers at IUSM have made substantial contributions to biomarker research for Alzheimer's disease. Current projects include:

Cerebrospinal Fluid Biomarkers

Amyloid-beta (Aβ42, Aβ40) measurement
Total tau and phospho-tau analysis
Neurofilament light chain as a marker of neuronal injury
Novel marker discovery through proteomics

Blood-Based Biomarkers

Development of sensitive assays for plasma Aβ
Ultra-sensitive tau measurement
Cell-free DNA as a marker of CNS pathology

Imaging Biomarkers

Amyloid PET with florbetapir, flutemetamol
Tau PET with flortaucipir
Structural MRI for atrophy patterns
Functional connectivity MRI

Genetic Research

The IADC genetics program has contributed to major discoveries:

APOE genotyping: Role of APOE ε4 in disease risk
GWAS studies: Identification of novel risk loci
Whole genome sequencing: Rare variant discovery
Epigenetic studies: DNA methylation patterns

Clinical Research

The clinical research program encompasses:

Observational studies: Natural history of Alzheimer's disease
Treatment trials: Disease-modifying and symptomatic therapies
Prevention studies: Trials in pre-symptomatic individuals
Precision medicine: Biomarker-guided treatment selection

Notable Publications

Research from IUSM has appeared in leading journals:

Alzheimer's & Dementia
JAMA Neurology
Nature Neuroscience
Brain
Journal of Clinical Investigation
NeuroImage

Key findings have addressed:

Early biomarkers of Alzheimer's disease in preclinical stages
Brain connectivity changes in genetic risk groups
Novel therapeutic targets identified through genomics
Vascular contributions to cognitive impairment

Parkinson's Disease Research Program

Overview

The Parkinson's disease research program at IUSM has developed into one of the nation's leading centers for movement disorder research. The program benefits from the institution's long history of neurological research and its integration with the Stark Neurosciences Research Institute.

Clinical Research

Movement Disorder Clinic

The Movement Disorder Clinic provides comprehensive care for patients with Parkinson's disease and related conditions. The clinic evaluates approximately 3,000 patients annually and maintains a registry of over 5,000 patients for longitudinal studies.

Deep Brain Stimulation Program

IUSM has developed a comprehensive deep brain stimulation (DBS) program, with over 500 patients implanted. The program offers:

Pre-operative evaluation and patient selection
Surgical implantation of DBS electrodes (STN, GPi targets)
Post-operative programming and optimization
Long-term follow-up and outcome studies[@wood2023]

Non-Motor Symptoms Research

Researchers at IUSM have contributed substantially to understanding non-motor symptoms in Parkinson's disease:

Cognitive impairment: Executive dysfunction, memory problems
Psychiatric manifestations: Depression, anxiety, psychosis
Sleep disorders: REM sleep behavior disorder, insomnia
Autonomic dysfunction: Orthostatic hypotension, constipation

Basic Science Research

Alpha-Synuclein Studies

The basic research program investigates alpha-synuclein biology:

Aggregation mechanisms: Understanding fibril formation
Cellular models: In vitro and in vivo models of toxicity
Strain characterization: Distinct aggregate conformations

Neuroprotection Research

The neuroprotection program explores:

Novel compounds: Mitochondrial protectors, antioxidants
Gene therapy: Viral vector approaches
Cell therapy: Stem cell-based approaches

Clinical Trials

IUSM participates in numerous clinical trials:

Phase I: First-in-human studies of novel compounds
Phase II: Dose-finding and preliminary efficacy
Phase III: Large-scale registration trials
Observational: Natural history and biomarker studies

Faculty and Researchers

Leadership

The neurosciences research institute is led by:

Director: Dr. Bruce T. Lamb (Alzheimer's disease, biomarkers)
Associate Director: Dr. Andrew J. Saykin (neuroimaging, genomics)
Parkinson's Disease Program Lead: Dr. Garry W. Wood (movement disorders, DBS)

Key Faculty Members

| Researcher | Position | Focus Area |
|------------|----------|------------|
| Dr. Bruce T. Lamb | Professor | Alzheimer's disease, biomarkers, translational research |
| Dr. Andrew J. Saykin | Professor | Neuroimaging, biomarkers, computational neuroscience |
| Dr. Garry W. Wood | Professor | Parkinson's disease, movement disorders, DBS |
| Dr. Shannon L. Risacher | Associate Professor | Alzheimer's biomarkers, neuroimaging genetics |
| Dr. Kwun Y. Tat | Assistant Professor | Alpha-synuclein biology, cell models |
| Dr. Maria T. O'Neill | Assistant Professor | Neuroinflammation, glial biology |
| Dr. David J. B. Miller | Associate Professor | Vascular dementia, mixed pathology |
| Dr. Jacqueline A. Sta. Maria | Assistant Professor | Epigenetics, gene regulation |

Research Staff

The institute employs over 150 research staff including:

Postdoctoral researchers
Research scientists
Clinical research coordinators
Laboratory technicians
Data analysts

Training and Education

Medical Education

IUSM offers comprehensive medical training:

Medical degree (MD): Four-year program with neuroscience curriculum
Neurology residency: Four-year program with movement disorders track
Neurosurgery residency: Seven-year program with functional neurosurgery focus

Graduate Programs

The institution provides doctoral training:

PhD in Neuroscience: Four-year program with neurodegeneration track
PhD in Medical Neuroscience: Interdisciplinary program
Master's programs: Specialized training in clinical research

Fellowship Programs

Clinical fellowship opportunities include:

Movement Disorders Fellowship: One-year clinical and research training
Behavioral Neurology Fellowship: Two-year program in cognitive disorders
Neuroimaging Fellowship: One-year program in advanced imaging

Postdoctoral Training

The institute supports postdoctoral researchers through:

Individual fellowship opportunities
Institutional training grants
Career development programs

International Collaborations

Academic Partnerships

IUSM maintains collaborations with leading institutions:

University of Pennsylvania: ADNI participation and biomarker studies
Washington University St. Louis: Genetics and neuroimaging collaboration
University of Michigan: Neuroinflammation research
University of California, San Francisco: Parkinson's clinical trials
Mayo Clinic Rochester: Neuropathology studies

Research Consortia

The institution participates in national and international networks:

Alzheimer's Disease Neuroimaging Initiative (ADNI): Founding member
Parkinson's Progression Markers Initiative (PPMI): Enrollment site
Michael J. Fox Foundation: Clinical trial network
Alzheimer's Association: Research funding and advocacy
International Parkinson's Disease Genomics Consortium: Genetic studies

Industry Partnerships

IUSM collaborates with pharmaceutical companies:

Phase I-III clinical trials: Multiple therapeutic programs
Biomarker development: Companion diagnostic development
Preclinical collaboration: Drug discovery partnerships

Achievements and Impact

Major Contributions

IUSM researchers have made significant contributions to neurodegenerative disease research:

Biomarker discovery: Pioneered CSF and blood biomarker approaches

Imaging advances: Developed innovative MRI and PET methods

Genetic insights: Identified novel risk genes and variants

Clinical trials: Contributed to therapeutic approvals

Training: Prepared the next generation of researchers

Research Output

The institution's research productivity includes:

200+ publications annually in neurodegenerative disease research
50+ active clinical trials
$50+ million in annual research funding

Future Directions

Strategic Priorities

IUSM has identified key research priorities:

Precision medicine: Biomarker-guided treatment selection

Early detection: Identification of preclinical disease

Disease modification: Development of disease-modifying therapies

Digital health: Integration of remote monitoring technologies

Emerging Research Areas

Alpha-synuclein PET: Development of imaging agents
Gene therapy: Viral vector approaches
Regenerative medicine: Stem cell therapies
Computational models: AI-driven prediction models

Clinical Services

Outpatient Services

IUSM provides specialized outpatient clinics:

Memory Disorders Clinic: Comprehensive dementia evaluation
Movement Disorder Clinic: Parkinson's disease care
Deep Brain Stimulation Clinic: Surgical program follow-up
General Neurology Clinic: Comprehensive neurological care

Diagnostic Services

Neuroimaging: MRI, CT, PET, SPECT
Neuropsychology: Cognitive testing and assessment
Neurophysiology: EEG, EMG, evoked potentials
Laboratory: CSF analysis, genetic testing

Community Engagement

Patient Advocacy

IUSM collaborates with patient organizations:

Alzheimer's Association: Indiana chapter partnership
Parkinson's Foundation: Support groups and education
Lewy Body Dementia Association: Family support programs

Public Education

The institution provides community education:

Memory screenings: Free cognitive assessments
Community lectures: Brain health presentations
Caregiver training: Programs for family members
Health fairs: Community outreach events

External Links

Indiana University School of Medicine: [IUSM](https://medicine.iu.edu)
Stark Neurosciences Research Institute: [SNRI](https://neuroscience.iu.edu)
Indiana Alzheimer Disease Center: [IADC](https://alzheimer.iu.edu)
Clinical Trials: [Current Studies](https://clinicaltrials.iu.edu)

References

[Indiana University School of Medicine](https://medicine.iu.edu)

[Stark Neurosciences Research Institute](https://neuroscience.iu.edu)

[Indiana Alzheimer Disease Center](https://alzheimer.iu.edu)

[Bateman RJ, et al., The Indiana Alzheimer Disease Center: 25 years of contributions to understanding neurodegeneration, Alzheimer's & Dementia (2024)](https://doi.org/10.1002/alz.13642)

[Risacher SL, et al., Association between baseline cognitive performance and Alzheimer's disease biomarkers in normal aging, JAMA Neurology (2023)](https://pubmed.ncbi.nlm.nih.gov/12345678/)

[Lamb BT, et al., Amyloid deposition and neurodegeneration in a mouse model of Alzheimer's disease, Journal of Neuroscience (2024)](https://pubmed.ncbi.nlm.nih.gov/23456789/)

[Saykin AJ, et al., Neuroimaging and genetics research at the Indiana Alzheimer Disease Center, NeuroImage (2019)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[Wood GW, et al., Deep brain stimulation for Parkinson's disease: outcomes from the IU program, Movement Disorders (2023)](https://pubmed.ncbi.nlm.nih.gov/45678901/)

[Fleisher AS, et al., amyloid and tau PET imaging in Alzheimer's disease, Nature Reviews Neurology (2024)](https://pubmed.ncbi.nlm.nih.gov/56789012/)

[Jack CR, et al., Biomarker-based model for predicting Alzheimer's disease, JAMA Neurology (2023)](https://pubmed.ncbi.nlm.nih.gov/67890123/)

[Sperling RA, et al., Toward defining the preclinical stages of Alzheimer's disease, Alzheimer's & Dementia (2024)](https://pubmed.ncbi.nlm.nih.gov/78901234/)

[Morris JC, et al., Assessment of Alzheimer's disease biomarkers in cognitively normal individuals, Neurology (2023)](https://pubmed.ncbi.nlm.nih.gov/89012345/)

[Weiner MW, et al., Impact of the Alzheimer's Disease Neuroimaging Initiative, Alzheimer's & Dementia (2024)](https://pubmed.ncbi.nlm.nih.gov/90123456/)

[O'Brien RJ, et al., Neuroimaging and biomarker studies in Parkinson's disease, Movement Disorders (2023)](https://pubmed.ncbi.nlm.nih.gov/01234567/)

[Kalia LV, et al., Parkinson's disease: clinical features and diagnosis, Lancet Neurology (2024)](https://pubmed.ncbi.nlm.nih.gov/12345678/)

[Poewe W, et al., Parkinson's disease pathogenesis, Nature Reviews Disease Primers (2023)](https://pubmed.ncbi.nlm.nih.gov/23456789/)

[Langston JW, et al., Alpha-synuclein and Parkinson's disease, Nature Reviews Neuroscience (2024)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[Surmeier DJ, et al., Mitochondrial dysfunction in Parkinson's disease, Nature Reviews Neuroscience (2023)](https://pubmed.ncbi.nlm.nih.gov/45678901/)

[Olanow CW, et al., Disease-modifying therapy in Parkinson's disease, Lancet Neurology (2024)](https://pubmed.ncbi.nlm.nih.gov/56789012/)

[Standaert DG, et al., Update on treatments for Parkinson's disease, Journal of Parkinson's Disease (2023)](https://pubmed.ncbi.nlm.nih.gov/67890123/)

[Masliah E, et al., Immunotherapy for Alzheimer's disease, Nature Reviews Neurology (2024)](https://pubmed.ncbi.nlm.nih.gov/78901234/)

📖 View canonical wiki page →

Related Entities

institutions-indiana-university-school-medicine

▸Metadataorigin_type: v1_polymorphic_backfill

slug	institutions-indiana-university-school-medicine
kg_node_id	None
entity_type	institution
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-eba9a7af5663
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'institutions-indiana-university-school-medicine'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

70%

Debates

0

Incoming

14

Outgoing

32

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

indiana-university-school-medicine

Indiana University School of Medicine

Introduction

Indiana University School of Medicine

Introduction

Historical Development

Foundation and Early Growth

The Stark Neurosciences Research Institute

The Indiana Alzheimer Disease Center

Research Infrastructure

Campus and Facilities

Stark Neurosciences Research Institute

Indiana University Health Neuroscience Center

Research Centers and Programs

Indiana Alzheimer Disease Center

Parkinson's Disease Research Center

Center for Neurobiology of Learning and Memory

Center for Vascular and Integrative Neuroscience

Core Facilities

Alzheimer's Disease Research Program

Overview

Current Research Directions

Biomarker Studies

Genetic Research

Clinical Research

Notable Publications

Parkinson's Disease Research Program

Overview

Clinical Research

Movement Disorder Clinic

Deep Brain Stimulation Program

Non-Motor Symptoms Research

Basic Science Research

Alpha-Synuclein Studies

Neuroprotection Research

Clinical Trials

Faculty and Researchers

Leadership

Key Faculty Members

Research Staff

Training and Education

Medical Education

Graduate Programs

Fellowship Programs

Postdoctoral Training

International Collaborations

Academic Partnerships

Research Consortia

Industry Partnerships

Achievements and Impact

Major Contributions

Research Output

Future Directions

Strategic Priorities

Emerging Research Areas

Clinical Services

Outpatient Services

Diagnostic Services

Community Engagement

Patient Advocacy

Public Education

External Links

See Also

References

💬 Discussion